OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Brucella abortus antigen omp25 vaccines: Development and targeting based on Lactococcus lactis
Somaye Tirbakhsh Gouran, Abbas Doosti, Mohammad Saeid Jami
Veterinary Medicine and Science (2023) Vol. 9, Iss. 4, pp. 1908-1922
Open Access | Times Cited: 7
Somaye Tirbakhsh Gouran, Abbas Doosti, Mohammad Saeid Jami
Veterinary Medicine and Science (2023) Vol. 9, Iss. 4, pp. 1908-1922
Open Access | Times Cited: 7
Showing 7 citing articles:
A novel vaccine strategy against Brucellosis using Brucella abortus multi-epitope OMPs vaccine based on Lactococcus lactis live bacterial vectors
Tohid Piri Gharaghie, Ghazal Ghajari, Golnoosh Rezaeizadeh, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112204-112204
Closed Access | Times Cited: 4
Tohid Piri Gharaghie, Ghazal Ghajari, Golnoosh Rezaeizadeh, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112204-112204
Closed Access | Times Cited: 4
Development of a plant-based vaccine against brucellosis: stable expression of Brucella abortus OMP25 in transgenic tobacco
Mansoure Qashqai, Emrah Bertan, Semiha Erişen, et al.
Transgenic Research (2025) Vol. 34, Iss. 1
Open Access
Mansoure Qashqai, Emrah Bertan, Semiha Erişen, et al.
Transgenic Research (2025) Vol. 34, Iss. 1
Open Access
Design of an oral vaccine using Lactococcus lactis against brucellosis: an in vitro and in vivo study
Mahsa Kazemi-Roudsari, Abbas Doosti, Mohammad‐Saeid Jami
AMB Express (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Mahsa Kazemi-Roudsari, Abbas Doosti, Mohammad‐Saeid Jami
AMB Express (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Immunogenicity and protective efficacy of a recombinant lactococcus lactis vaccine against HSV-1 infection
Shaoju Qian, Ruixue Li, Yeqing He, et al.
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Shaoju Qian, Ruixue Li, Yeqing He, et al.
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Construction of recombinant Omp25 or EipB protein loaded PLGA nanovaccines for Brucellosis protection
İlkgül Akmayan, Sedanur Oztav, Irem Coksu, et al.
Nanotechnology (2024) Vol. 35, Iss. 39, pp. 395707-395707
Open Access | Times Cited: 2
İlkgül Akmayan, Sedanur Oztav, Irem Coksu, et al.
Nanotechnology (2024) Vol. 35, Iss. 39, pp. 395707-395707
Open Access | Times Cited: 2
A comprehensive investigation of the medicinal efficacy of antimicrobial fusion peptides expressed in probiotic bacteria for the treatment of pan drug-resistant (PDR) infections
Maryam Safarpour-Dehkordi, Omid Chabok, Mohsen Asgari, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 3
Closed Access | Times Cited: 1
Maryam Safarpour-Dehkordi, Omid Chabok, Mohsen Asgari, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 3
Closed Access | Times Cited: 1
Immunization of BALB/c mice with BAB1-0278: An initial investigation of a novel potential vaccine for brucellosis based on Lactococcus Lactis vector
Donya Kazemi, Abbas Doosti, Mostafa Shakhsi-Niaei
Microbial Pathogenesis (2023) Vol. 185, pp. 106417-106417
Closed Access
Donya Kazemi, Abbas Doosti, Mostafa Shakhsi-Niaei
Microbial Pathogenesis (2023) Vol. 185, pp. 106417-106417
Closed Access
